| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/21/1999 | CN1223546A Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 07/21/1999 | CN1223266A Thymosin alpha-1 derivatives |
| 07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 07/20/1999 | US5925751 Human cytomegalovirus DNA sequences |
| 07/20/1999 | US5925750 Nucleic acid encoding polypeptide of a growth factor receptor family |
| 07/20/1999 | US5925748 DNA diagnostics for glaucoma |
| 07/20/1999 | US5925742 Protein affecting KATP channels |
| 07/20/1999 | US5925741 A specific aspect of the present invention concerns bae which are revealed after virus-receptor interaction, e.g. hiv-cd4 interaction. |
| 07/20/1999 | US5925739 Pharmaceutical formulation for subcutaneous intramuscular or intradermal administration of factor VIII |
| 07/20/1999 | US5925738 Stable aqueous liquid of plasma protein, buffer, calcium ions, and osmotic modulating agent; for treatment of blood disorders by administration of blood coagulation factors |
| 07/20/1999 | US5925736 Collagen-based methods and formulations for the treatment of arthritis |
| 07/20/1999 | US5925735 Hematopoietic cytokine receptor |
| 07/20/1999 | US5925734 The viral proteins also have superantigen-like activity, and inhibit ebv infection. |
| 07/20/1999 | US5925731 Endothelin antagonist peptides |
| 07/20/1999 | US5925730 Decapeptide gonadotrophin releasing hormone antagonists; for antifertility agents especially for males; precocious puberty; dysmenorrhea; antitumor/anticarcinogenic agents; endometriosis |
| 07/20/1999 | US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology |
| 07/20/1999 | US5925643 Treating human immunodeficiency virus infections |
| 07/20/1999 | US5925633 3-Substituted-4-oxa-1-azabicyclo 3,2,0!heptan-7-one as cysteine protease inhibitors |
| 07/20/1999 | US5925626 Hyaluronic acid fractions having pharmaceutical activity, and pharmaceutical compositions containing the same |
| 07/20/1999 | US5925620 Treatment of allergies, autoaggressive disease and tumors |
| 07/20/1999 | US5925619 Formulation for peptide release |
| 07/20/1999 | US5925618 Peptides useful as somatostatin antagonists |
| 07/20/1999 | US5925617 Administering biodegradable mixtures of tri-, tetra- or pentapeptides with glycolic acid-lactic acid copolymer after cataract removal to inhibit cell adhesion |
| 07/20/1999 | US5925568 It is also useful to be able to harvest haematopoietic cells prior to chemotherapy or radiotherapy, thus protecting them from the effects of this therapy; after therapy, the cells can be returned to the patient. |
| 07/20/1999 | US5925566 Signal transduction polypeptide with two zinc finger domains; binds to epidermal growth factor receptor and released after activation to localize in nucleolus; anticarcinogenic agents; angiogenesis inhibitors |
| 07/20/1999 | US5925564 Expression vector systems and method of use |
| 07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
| 07/20/1999 | US5925549 Soluble 7-transmembrane domain G-protein-coupled receptor compositions and methods |
| 07/20/1999 | US5925548 Disclosed are various dna, protein and cellular compositions and methods of making and using such constitutively active receptors. |
| 07/20/1999 | US5925547 Nucleic acid encoding novel protein domain which binds tyrosine phosphorylated proteins |
| 07/20/1999 | US5925542 Nucleic acid encoding human phosphodiesterase regulatory subunit |
| 07/20/1999 | US5925541 The invention may be used in a process which enzymatically de-antigenizes human erythrocytes bearing a.sub.1 antigen. |
| 07/20/1999 | US5925539 Human pelota homolog |
| 07/20/1999 | US5925536 Receptor-type phosphotyrosine phosphatase-β |
| 07/20/1999 | US5925528 Murine cell lines which over produce acidic fibroblast growth factor (aFGF) and method of using same |
| 07/20/1999 | US5925526 Paraneoplastic cerebellar degeneration (pcd) is a disorder of the cerebellum found in association with neoplasms usually of lung, ovary, breast, or hodgkins disease. |
| 07/20/1999 | US5925521 Human serine carboxypeptidase |
| 07/20/1999 | US5925516 Medicaments for the treatment of papillomavirus diseases |
| 07/20/1999 | US5925363 Cosmetic composition containing, in combination, a superoxide-dismutase and a melanin pigment |
| 07/20/1999 | US5925352 Administering antiinflammatory amount of anti-neutrophil chemotactic factor antibodies |
| 07/20/1999 | US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 07/20/1999 | US5925350 Use of preparation comprising a plasminogen activator to improve wound healing |
| 07/20/1999 | US5925349 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| 07/20/1999 | US5925348 Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin |
| 07/20/1999 | US5925346 Antisense strategy for the production of species specific viral insecticides |
| 07/20/1999 | US5925344 Pharmaceutical composition and uses therefor |
| 07/20/1999 | US5925342 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| 07/20/1999 | US5925333 Screening for compounds that alter the binding by scavengers |
| 07/20/1999 | CA2155001C Htlv-i and htlv-ii gp21 derived peptides for use in diagnostics |
| 07/20/1999 | CA2146367C Calcium channel blocking polypeptides from heteropoda venatoria |
| 07/20/1999 | CA2137638C Anti gangliosides monoclonal antibodies and their use in the specific active immunotherapy of malignant tumors |
| 07/20/1999 | CA2087730C Use of crosslinked crystals as a novel form of enzyme immobilization |
| 07/20/1999 | CA2082394C Pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/20/1999 | CA2060223C Injectable medical lubricating fluid composition and method of use |
| 07/20/1999 | CA1340667C Peptides having bradykinin antagonist action |
| 07/20/1999 | CA1340656C Membrane anchor/active compound conjugate, its preparation and its use |
| 07/19/1999 | CA2227337A1 Use of fructose diphosphate to reduce cyclosporine dosages after organ transplantation |
| 07/15/1999 | WO1999035283A1 Methods and reagents for modulating cell motility |
| 07/15/1999 | WO1999035277A2 Recombinant, active caspases and uses thereof |
| 07/15/1999 | WO1999035275A1 Human genetic sequences which are homologous to the yeast genes involved in the proteolytic processing of prenylated proteins |
| 07/15/1999 | WO1999035270A1 Streptococcal heat shock proteins of the hsp60 family |
| 07/15/1999 | WO1999035267A1 Human and murine il-17d, cytokine related to interleukin-17: dna and polypeptides |
| 07/15/1999 | WO1999035266A2 Human urotensin ii |
| 07/15/1999 | WO1999035265A1 Human vps35/mem3-related protein |
| 07/15/1999 | WO1999035262A2 Apoptosis inducing molecule ii |
| 07/15/1999 | WO1999035260A1 Non-identical genes and their application in improved molec ular adjuvants |
| 07/15/1999 | WO1999035259A1 Identification of lysolipid receptors involved in inflammatory response |
| 07/15/1999 | WO1999035257A1 Target for treating atherosclerosis, obesity and type ii diabetes |
| 07/15/1999 | WO1999035253A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035247A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd |
| 07/15/1999 | WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/15/1999 | WO1999035243A2 Extension of cellular lifespan, methods and reagents |
| 07/15/1999 | WO1999035169A2 Methods and compositions for treating and diagnosing insulin related disorders |
| 07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035166A1 Compounds and methods for modulating occludin related tissue permeability |
| 07/15/1999 | WO1999035164A1 Anti-cryptococcal peptides |
| 07/15/1999 | WO1999035163A1 Phenylalanine derivatives |
| 07/15/1999 | WO1999035162A1 Therapeutic liposome-encapsulated immunomodulators |
| 07/15/1999 | WO1999035160A1 Human fk506 binding proteins |
| 07/15/1999 | WO1999035158A1 36 human secreted proteins |
| 07/15/1999 | WO1999034844A1 Bone material |
| 07/15/1999 | WO1999034835A1 Gene therapy of tumors using non-viral delivery system |
| 07/15/1999 | WO1999034834A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/15/1999 | WO1999034830A1 Topical ophthalmic preparations containing immunosuppressive agents |
| 07/15/1999 | WO1999034827A1 Activated t-cells and their uses |
| 07/15/1999 | WO1999034826A1 Methods and compositions for desensitisation |
| 07/15/1999 | WO1999034823A2 METHODS FOR PREVENTING AND TREATING FIBROTIC DISEASES RESULTING FROM ACCUMULATION OF EXCESS EXTRACELLULAR MATRIX INDUCED BY TGFβ USING RENIN INHIBITORS |
| 07/15/1999 | WO1999034822A1 Formulations for amylin agonist peptides |
| 07/15/1999 | WO1999034821A1 Stabilised insulin compositions |
| 07/15/1999 | WO1999034820A1 New use of heparin-binding growth-associated molecule |
| 07/15/1999 | WO1999034819A2 Use of citrulline peptides derived from filaggrin for treating autoimmune diseases |
| 07/15/1999 | WO1999034818A1 Broad spectrum chemokine antagonist and uses thereof |
| 07/15/1999 | WO1999034817A1 Agent for treating allergic or hypersensitivity condition |
| 07/15/1999 | WO1999034816A1 Method for administering monomeric insulin analogs |
| 07/15/1999 | WO1999034815A1 Method for administering aspb28-human insulin |
| 07/15/1999 | WO1999034814A1 Interferon responsive transcript |
| 07/15/1999 | WO1999034813A1 Supplement for dialysis patients |
| 07/15/1999 | WO1999034777A1 Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus |
| 07/15/1999 | WO1999034764A2 Amylin agonist pharmaceutical compositions containing insulin |